Litigation

Brain Injury: Active Clinical Trials

By Michael Kaplen

The Brain Trauma Foundation (BTF) has annouced their next interactive web based lecture topic: Current Active Clinical Trials in TBI  in their Lunchtime Lecture series.  The program is scheudled for October 14, 2009 from 12:00-1:00 PM EDT for a live, interactive, web-based lecture on Current Active Clinical Trials in TBI.

BTF?s Lunchtime Lectures are a monthly, one-hour online lecture series taught by top neurotrauma care experts on various up-to-date topics related to traumatic brain injury (TBI).  An excellent opportunity for all healthcare professionals, these live, interactive lectures are complete with slides and audio and easily accessible through an Internet

Lecture Description: Traumatic brain injury is the leading cause of death under age 45 in the Western World. Despite the efforts of investigators worldwide, no phase III clinical has yet been successful. However, recent advances in clinical trial design and implementation leverage lessons learned from past failures. At present, several promising interventions are being tested through multicenter clinical trials, including progesterone, citicholine, and anti-apoptotic agents. This lecture will discuss clinical trial design factors as well as describe current and impending clinical trials for the treatment of traumatic brain injury.

 Learning Ojbectives: 
? Discuss the current active multicenter clinical trials in traumatic brain injury.
? Discuss limitations of clinical trial design impacting recent clinical trial failures.
? Discuss clinical trials in traumatic brain injury set to launch in the next year.

You can access registration information by clicking here.

Full post as published by Brain Injury News and Information on October 07, 2009 (boomark / email).